TORNTPHARMNSETorrent Pharmaceuticals Limited· PharmaceuticalsMediumNeutral
Announced Mon, 30 Mar · 20:08 IST

Torrent Pharmaceuticals Limited has informed the Exchange about General Updates

Strategic Transactions View source PDF

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.5%1-day move
₹4221.10
prior close
₹4277.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.8+0.9+0.2-5.5-4.9-4.3-4.5-3.3-1.5-2.6+1.0+3.0+10.0
Up moveDown movePending
AI summary

Torrent Pharmaceuticals has sold 50,000 equity shares of UNM Foundation, a Section 8 (non-profit) associate company, to its holding company Torrent Investments Limited for a total consideration of ₹5,00,000 (face value ₹10 per share). The transaction was completed on March 30, 2026. Since UNM is a Section 8 company, it generates no revenue or turnover. The deal is a related party transaction (buyer is the promoter and holding company) and has been carried out at arm's length. No sale agreement was executed as the buyer is the holding company itself.

Likely market impact

This is a minor internal restructuring with negligible financial impact (₹5 lakhs) involving a non-profit associate. It is unlikely to have any material effect on shareholders or the stock price, as it simply transfers a small non-operating associate entity within the promoter group.